Document Detail


A computer simulation model of the cost-effectiveness of routine Staphylococcus aureus screening and decolonization among lung and heart-lung transplant recipients.
MedLine Citation:
PMID:  24500598     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Our objective was to model the cost-effectiveness and economic value of routine peri-operative Staphylococcus aureus screening and decolonization of lung and heart-lung transplant recipients from hospital and third-party payer perspectives. We used clinical data from 596 lung and heart-lung transplant recipients to develop a model in TreeAge Pro 2009 (Williamsport, MA, USA). Sensitivity analyses varied S. aureus colonization rate (5-15 %), probability of infection if colonized (10-30 %), and decolonization efficacy (25-90 %). Data were collected from the Cardiothoracic Transplant Program at the University of Pittsburgh Medical Center. Consecutive lung and heart-lung transplant recipients from January 2006 to December 2010 were enrolled retrospectively. Baseline rates of S. aureus colonization, infection and decolonization efficacy were 9.6 %, 36.7 %, and 31.9 %, respectively. Screening and decolonization was economically dominant for all scenarios tested, providing more cost savings and health benefits than no screening. Savings per case averted (2012 $US) ranged from $73,567 to $133,157 (hospital perspective) and $10,748 to $16,723 (third party payer perspective), varying with the probability of colonization, infection, and decolonization efficacy. Using our clinical data, screening and decolonization led to cost savings per case averted of $240,602 (hospital perspective) and averted 6.7 S. aureus infections (4.3 MRSA and 2.4 MSSA); 89 patients needed to be screened to prevent one S. aureus infection. Our data support routine S. aureus screening and decolonization of lung and heart-lung transplant patients. The economic value of screening and decolonization was greater than in previous models of other surgical populations.
Authors:
C J Clancy; S M Bartsch; M H Nguyen; D R Stuckey; R K Shields; B Y Lee
Related Documents :
19542548 - Enemies or allies? the organ transplant medical community, the federal government, and ...
23591208 - Renal perfusion assessment by renal doppler during fluid challenge in sepsis.
19392728 - The use of drotrecogin alfa (activated) in solid organ transplant patients: a case series.
19269108 - Hypothermic preconditioning of donor organs prior to harvesting and ischaemia using ice...
15016038 - Prevalence of gingival overgrowth in transplant patients immunosuppressed with tacrolimus.
12353348 - Phaeohyphomycosis caused by exophiala species in immunocompromised hosts.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-2-7
Journal Detail:
Title:  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology     Volume:  -     ISSN:  1435-4373     ISO Abbreviation:  Eur. J. Clin. Microbiol. Infect. Dis.     Publication Date:  2014 Feb 
Date Detail:
Created Date:  2014-2-6     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8804297     Medline TA:  Eur J Clin Microbiol Infect Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Variability in accreditation council for graduate medical education resident case log system practic...
Next Document:  Dynamic evolution and immunoreactivity of aptamers binding to polyclonal antibodies against MPT64 an...